Andrea Sbrana

14PUBLICATIONS
42CO-AUTHORS
Molecular targetsEpidemiological modellingHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 13, 2025
Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature Review.

Rebecca Sparavelli, Rossella Bruno, Alessandra Celi

|Feb 13, 2025
Prognostic Stratification of Epithelioid Pleural Mesothelioma Based on the Hippo-TEADs Network.

Anello Marcello Poma, Rossella Bruno, Iacopo Petrini

|Jul 13, 2024
Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Andrea Camerini, Francesca Mazzoni, Vieri Scotti

|May 06, 2024
Dabrafenib-trametinib in BRAF V600-mutated non-small-cell lung cancer: a single center real world experience.

Andrea Sbrana, Sabrina Cappelli, Iacopo Petrini

Pageof 3